Total Payments
$8,223
2024 Payments
$1,036
Companies
44
Transactions
442
Medicare Patients
353
Medicare Billing
$5,829
Payment Breakdown by Category
Food & Beverage$7,593 (92.3%)
Travel$627.86 (7.6%)
Education$1.79 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,593 | 439 | 92.3% |
| Travel and Lodging | $627.86 | 2 | 7.6% |
| Education | $1.79 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,114 | 84 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $1,011 | 8 | $0 (2017) |
| ABBVIE INC. | $763.36 | 82 | $0 (2024) |
| Lilly USA, LLC | $763.22 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $403.89 | 24 | $0 (2024) |
| Novo Nordisk Inc | $294.73 | 20 | $0 (2021) |
| PFIZER INC. | $288.23 | 12 | $0 (2021) |
| Indivior Inc. | $287.38 | 13 | $0 (2024) |
| Alkermes, Inc. | $282.26 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $258.16 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,036 | 58 | ABBVIE INC. ($180.51) |
| 2023 | $1,082 | 63 | Axsome Therapeutics, Inc. ($187.61) |
| 2022 | $1,045 | 61 | ABBVIE INC. ($240.27) |
| 2021 | $988.04 | 70 | AbbVie Inc. ($159.49) |
| 2020 | $997.18 | 69 | Otsuka America Pharmaceutical, Inc. ($276.92) |
| 2019 | $789.52 | 49 | Otsuka America Pharmaceutical, Inc. ($341.54) |
| 2018 | $738.88 | 43 | Otsuka America Pharmaceutical, Inc. ($253.45) |
| 2017 | $1,547 | 29 | Ironwood Pharmaceuticals, Inc ($1,011) |
All Payment Transactions
442 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Obesity | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: OUD | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: CNS | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardio-renal | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Endocrinology | ||||||
| 08/27/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: OUD | ||||||
| 08/22/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $70.83 | General |
| Category: CNS | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $48.10 | General |
| Category: ANTIBIOTIC | ||||||
| 08/13/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Opioid Use Disorder | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 111 | 200 | $5,728 | $1,556 |
| 2020 | 8 | 242 | 474 | $17,632 | $4,273 |
Total Patients
353
Total Services
674
Medicare Billing
$5,829
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 17 | $2,011 | $517.66 | 25.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 11 | 32 | $901.00 | $403.20 | 44.8% |
| 85610 | Blood test, clotting time | Office | 2021 | 13 | 63 | $568.00 | $266.38 | 46.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 53 | 53 | $2,016 | $247.43 | 12.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 22 | 35 | $232.00 | $121.80 | 52.5% |
| 17000 | Destruction of skin growth | Office | 2020 | 24 | 30 | $2,250 | $1,358 | 60.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 89 | 92 | $5,152 | $761.38 | 14.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 27 | $2,406 | $575.66 | 23.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 24 | $4,237 | $539.57 | 12.7% |
| 85610 | Blood test, clotting time | Office | 2020 | 17 | 117 | $1,170 | $498.06 | 42.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 17 | 66 | $1,650 | $282.01 | 17.1% |
| 81002 | Urinalysis, manual test | Office | 2020 | 46 | 59 | $354.00 | $196.89 | 55.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 20 | 59 | $413.00 | $60.94 | 14.8% |
About Dr. Samuel Gillespie, MD
Dr. Samuel Gillespie, MD is a Community Health Worker healthcare provider based in Moulton, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184612095.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Gillespie, MD has received a total of $8,223 in payments from pharmaceutical and medical device companies, with $1,036 received in 2024. These payments were reported across 442 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,593).
As a Medicare-enrolled provider, Gillespie has provided services to 353 Medicare beneficiaries, totaling 674 services with total Medicare billing of $5,829. Data is available for 2 years (2020–2021), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Community Health Worker
- Other Specialties Dermatology, Adult Medicine
- Location Moulton, AL
- Active Since 10/13/2005
- Last Updated 03/07/2023
- Taxonomy Code 172V00000X
- Entity Type Individual
- NPI Number 1184612095
Products in Payments
- REXULTI (Drug) $1,150
- ZURAMPIC (Drug) $986.04
- VRAYLAR (Drug) $557.46
- TRULICITY (Drug) $369.12
- Kerendia (Drug) $258.16
- SUBLOCADE (Drug) $256.49
- LYBALVI (Drug) $256.17
- MOUNJARO (Drug) $221.73
- UBRELVY (Drug) $211.18
- Auvelity (Drug) $206.05
- JARDIANCE (Drug) $190.36
- BREZTRI (Drug) $181.47
- FREESTYLE LIBRE 2 (Device) $170.96
- Tresiba (Drug) $161.48
- FARXIGA (Drug) $158.04
- ENTRESTO (Drug) $156.99
- Zubsolv (Drug) $144.20
- Otezla (Drug) $140.71
- Vascepa (Drug) $127.22
- XIFAXAN (Drug) $119.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.